0001209191-22-034385.txt : 20220603
0001209191-22-034385.hdr.sgml : 20220603
20220603201910
ACCESSION NUMBER: 0001209191-22-034385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220602
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Mark
CENTRAL INDEX KEY: 0001734389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 22996460
MAIL ADDRESS:
STREET 1: 20 BERKELEY SQUARE, MAYFAIR
CITY: LONDON
STATE: X0
ZIP: W1J 6EQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMARA Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-206-2020
MAIL ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-02
0
0001672619
IMARA Inc.
IMRA
0001734389
Chin Mark
C/O IMARA INC.
116 HUNTINGTON AVE, SIXTH FLOOR
BOSTON
MA
02116
1
0
0
0
Common Stock
2344072
I
By entities affiliated with Arix Bioscience plc
Stock Options (Right to Buy)
1.07
2022-06-02
4
A
0
8500
0.00
A
2032-06-01
Common Stock
8500
8500
D
The shares are directly beneficially owned by Arix Bioscience Holdings Limited ("Arix Ltd."). Arix Bioscience Plc ("Arix Plc") is the sole owner and parent of Arix Ltd. and may be deemed to indirectly beneficially own the shares held by Arix Ltd. Mr. Chin is a managing director of Arix plc. Each of Arix plc and Mr. Chin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant.
/s/ Michael P. Gray, Attorney-in-Fact
2022-06-03